Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTU-520 in Distal Subungual Onychomycosis
NCT01400594Phase 2Completed
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jul 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in onychomycosis comparing HTU-520 Patch with Placebo Patch (2 arms). Primary endpoint: Complete Cure (Mycological Cure + Clinical Cure) at 48 weeks. Started Jul 2011; status: completed.
02
Drugs
terbinafine hydrochloride patch
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT01400594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400594.